Ongoing Clinical Trials
Pursuing Parallel Monotherapy and Combination Therapy Pathways
Clinical Trial | Indication | #Patients | Highlights |
Phase 2 Dose Escalation Trial ![]() ClinicalTrials.gov: NCT04375878 |
Cystic Fibrosis | 30 |
|
Phase 2 Combination Therapy Dose Escalation Trial![]() ClinicalTrials.gov: NCT04302662 |
Cystic Fibrosis Severe EPI |
20-24 |
|